CLBS14
/ Lisata Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 08, 2021
ACT34-CMI -- Adult Autologous CD34+ Cells
(clinicaltrials.gov)
- P2; N=321; Completed; Sponsor: Caladrius Biosciences, Inc.; N=150 ➔ 321
Clinical • Enrollment change • Cardiovascular • Myocardial Ischemia
1 to 1
Of
1
Go to page
1